Works by David, Kakiashvili


Results: 11
    1

    High risk NSGCT: case for surveillance.

    Published in:
    World Journal of Urology, 2009, v. 27, n. 4, p. 441, doi. 10.1007/s00345-009-0453-6
    By:
    • Kakiashvili, David;
    • Zuniga, Alvaro;
    • Jewett, Michael
    Publication type:
    Article
    2

    Chemoprevention of bladder cancer.

    Published in:
    World Journal of Urology, 2006, v. 24, n. 5, p. 445, doi. 10.1007/s00345-006-0123-x
    By:
    • Golijanin, Dragan;
    • Kakiashvili, David;
    • Madeb, Ralph;
    • Messing, Edward;
    • Lerner, Seth
    Publication type:
    Article
    3
    4
    5

    Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscleinvasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin.

    Published in:
    Urology Annals, 2011, v. 3, n. 3, p. 119, doi. 10.4103/0974-7796.84954
    By:
    • Alkhateeb, Sultan S.;
    • Neill, Mischel;
    • Bar-Moshe, Sas;
    • Rhijn, Bas Van;
    • Kakiashvili, David M.;
    • Fleshner, Neil;
    • Jewett, Michael;
    • Petein, Michel;
    • Schulman, Claude;
    • Hanna, Sally;
    • Bostrom, Peter J.;
    • Roumeguere, Thierry;
    • Shariat, Shahrokh F.;
    • Rorive, Sandrine;
    • Zlotta, Alexandre R.
    Publication type:
    Article
    6
    7
    8
    9
    10

    Pathological stage review is indicated in primary pT1 bladder cancer.

    Published in:
    BJU International, 2010, v. 106, n. 2, p. 206, doi. 10.1111/j.1464-410X.2009.09100.x
    By:
    • Van Rhijn, Bas W. G.;
    • Van der Kwast, Theo H.;
    • Kakiashvili, David M.;
    • Fleshner, Neil E.;
    • van der Aa, Madelon N. M.;
    • Alkhateeb, Sultan;
    • Bangma, Chris H.;
    • Jewett, Michael A. S.;
    • Zlotta, Alexandre R.
    Publication type:
    Article
    11